Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
Multicenter, open label, prospective study including successively a phase I trial and then a
phase II trial Phase I : Open label, non-randomized, sequential dose escalation of both
drugs, vinblastine and nilotinib.